{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:04:18Z","timestamp":1795122258801,"version":"4.10.3"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Anaplastic large cell lymphomas (ALCLs) are broadly classified into ALK-positive and ALK-negative. ALK-negative ALCL is composed of <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>-rearranged, <jats:italic toggle=\"yes\">TP63<\/jats:italic>-rearranged, and triple-negative cases. While lymphoid enhancer\u2013binding factor (LEF1) plays a crucial role in T-cell maturation, limited data exist on its expression in T-cell lymphomas, including ALCL. We characterized the expression of LEF1 in ALCL by immunohistochemistry. LEF1 nuclear expression in the neoplastic cells was graded as negative (0), weak (1+), intermediate (2+), or strong (3+), with the percentage of LEF1-positive neoplastic cells recorded. A total of 45 ALCL cases were evaluated, of which 16 were <jats:italic toggle=\"yes\">DUSP22-<\/jats:italic>rearranged. About 93.8% (15\/16) <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>-rearranged cases showed strong expression of LEF1 in &gt;75% tumor cells, compared with 3.4% (1\/29) non\u2013<jats:italic toggle=\"yes\">DUSP22<\/jats:italic>-rearranged ALCL (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). The striking association of LEF1 protein overexpression with <jats:italic toggle=\"yes\">DUPS22<\/jats:italic> rearrangement in ALCL was further confirmed by a gene expression profiling study which revealed significantly higher <jats:italic toggle=\"yes\">LEF1<\/jats:italic> expression in <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>-rearranged ALCL compared with other ALCL subtypes (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001). Although LEF1 is a nuclear mediator of the Wnt\/\u03b2-catenin pathway, <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic> RNA and protein levels were not overexpressed in LEF1-positive cases, suggesting the LEF1 overexpression in ALCL may not be involved in the Wnt\/\u03b2-catenin pathway. The strong and uniform LEF1 expression pattern has a high positive predictive value (93.8%) and high negative predictive value (96%) for <jats:italic toggle=\"yes\">DUSP22<\/jats:italic> rearrangement in ALK-negative ALCL. The combination of characteristic morphologic and molecular features of <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>-rearranged cases with the high LEF1 expression further emphasizes that <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>-rearranged ALCL represents a distinct clinicopathologic subset of ALCL.<\/jats:p>","DOI":"10.1097\/pas.0000000000001614","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T21:01:32Z","timestamp":1604869292000},"page":"550-557","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Aishwarya","family":"Ravindran","sequence":"first","affiliation":[{"name":"Division of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Division of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Division of Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Dasari","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Rech","sequence":"additional","affiliation":[{"name":"Division of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen D.","family":"McPhail","sequence":"additional","affiliation":[{"name":"Division of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Kurtin","sequence":"additional","affiliation":[{"name":"Division of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[{"name":"Division of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5858\/2010-0507-RAR.1","article-title":"Anaplastic large cell lymphoma: twenty-five years of discovery","volume":"135","author":"Kinney","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.3324\/haematol.2018.205880","article-title":"DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK\/STAT surrogate markers","volume":"104","author":"Onaindia","year":"2019","journal-title":"Haematologica"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri1529","article-title":"WNT signalling and haematopoiesis: a WNT-WNT situation","volume":"5","author":"Staal","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","article-title":"LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis","volume":"116","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1101\/gad.14.15.1837","article-title":"Wnt signaling and cancer","volume":"14","author":"Polakis","year":"2000","journal-title":"Genes Dev"},{"key":"R13-20250608","first-page":"1389","article-title":"Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment","volume":"7","author":"Santiago","year":"2017","journal-title":"Am J Cancer Res"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9440(10)64287-3","article-title":"Loss of expression of the WNT\/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas","volume":"162","author":"Dorfman","year":"2003","journal-title":"Am J Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1101\/gad.9.8.995","article-title":"Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions","volume":"9","author":"Giese","year":"1995","journal-title":"Genes Dev"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1074-7613(00)80454-9","article-title":"Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1","volume":"8","author":"Okamura","year":"1998","journal-title":"Immunity"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","article-title":"Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations","volume":"95","author":"Geissinger","year":"2010","journal-title":"Haematologica"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\u201cDouble-hit\u201d of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.immuni.2012.08.009","article-title":"The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy","volume":"37","author":"Yu","year":"2012","journal-title":"Immunity"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:02:48Z","timestamp":1749420168000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001614","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}